 |
1O9U |
GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH AXIN PEPTIDE |
B |
A |
Protein kinase-like (PK-like) |
|
 |
1OKV |
CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ILE-PHE-NH2 |
E |
B |
Cyclin-like |
|
 |
1WBP |
SRPK1 BOUND TO 9MER DOCKING MOTIF PEPTIDE |
B |
C |
|
|
 |
2BFY |
COMPLEX OF AURORA-B WITH INCENP AND HESPERIDIN. |
D |
A |
|
|
 |
2BZK |
CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH AMPPNP AND PIMTIDE |
A |
B |
|
|
 |
2C3I |
CRYSTAL STRUCTURE OF HUMAN PIM1 IN COMPLEX WITH IMIDAZOPYRIDAZIN I |
A |
B |
|
|
 |
2G1T |
A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain |
G |
C |
|
|
 |
2GU8 |
Discovery of 2-Pyrimidyl-5-Amidothiophenes as Novel and Potent Inhibitors for AKT: Synthesis and SAR Studies |
C |
A |
|
|
 |
2IZX |
MOLECULAR BASIS OF AKAP SPECIFICITY FOR PKA REGULATORY SUBUNITS |
C |
AB |
|
|
 |
2JAM |
CRYSTAL STRUCTURE OF HUMAN CALMODULIN-DEPENDENT PROTEIN KINASE I G |
D |
A |
|
|
 |
2JDO |
STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO)ETHYL) AMIDE |
C |
A |
Protein kinase-like (PK-like) |
|
 |
2JDR |
STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH THE INHIBITOR A-443654 |
C |
A |
Protein kinase-like (PK-like) |
|
 |
2JDS |
STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A-443654 |
I |
A |
Protein kinase-like (PK-like) |
|
 |
2JDT |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO)ETHYL) AMIDE |
I |
A |
|
|
 |
2JDV |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH A-443654 |
I |
A |
|
|
 |
2JLD |
EXTREMELY TIGHT BINDING OF RUTHENIUM COMPLEX TO GLYCOGEN SYNTHASE KINASE 3 |
E |
A |
|
|
 |
2ODB |
The crystal structure of human cdc42 in complex with the CRIB domain of human p21-activated kinase 6 (PAK6) |
B |
A |
|
|
 |
2OKR |
Crystal Structure of the P38a-MAPKAP kinase 2 Heterodimer |
C |
A |
Protein kinase-like (PK-like) |
|
 |
2Q0N |
Structure of human p21 activating kinase 4 (PAK4) in complex with a consensus peptide |
B |
A |
|
|
 |
2QME |
Crystal structure of human RAC3 in complex with CRIB domain of human p21-activated kinase 1 (PAK1) |
I |
A |
|
|
 |
2UVX |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 7-AZAINDOLE |
I |
A |
|
|
 |
2UVY |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH METHYL-(4-(9H-PURIN-6-YL)-BENZYL)-AMINE |
I |
A |
|
|
 |
2UVZ |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH C-PHENYL-C-(4-(9H-PURIN-6-YL)-PHENYL)-METHYLAMINE |
I |
A |
|
|
 |
2UW0 |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 6-(4-(4-(4-CHLORO-PHENYL)-PIPERIDIN-4-YL)-PHENYL)-9H-PURINE |
I |
A |
|
|
 |
2UW3 |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 5-METHYL-4-PHENYL-1H-PYRAZOLE |
I |
A |
|
|
 |
2UW4 |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 2-(4-(5-METHYL-1H-PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE |
I |
A |
|
|
 |
2UW5 |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (R)-2-(4-CHLORO-PHENYL)-2-(4-1H-PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE |
I |
A |
|
|
 |
2UW6 |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (S)-2-(4-CHLORO-PHENYL)-2-(4-1H-PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE |
I |
A |
|
|
 |
2UW7 |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 4-(4-CHLORO-PHENYL)-4-(4-(1H-PYRAZOL-4-YL)-PHENYL)-PIPERIDINE |
I |
A |
|
|
 |
2UW8 |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 2-(4-CHLORO-PHENYL)-2-PHENYL-ETHYLAMINE |
I |
A |
|
|
 |
2UW9 |
STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH 4-(4-CHLORO-PHENYL)-4-(4-(1H-PYRAZOL-4-YL)-PHENYL)-PIPERIDINE |
C |
A |
Protein kinase-like (PK-like) |
|
 |
2UZT |
PKA STRUCTURES OF AKT, INDAZOLE-PYRIDINE INHIBITORS |
B |
A |
|
|
 |
2UZU |
PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS |
I |
E |
|
|
 |
2UZV |
PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS |
2 |
A |
|
|
 |
2UZW |
PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS |
I |
E |
|
|
 |
2V3S |
STRUCTURAL INSIGHTS INTO THE RECOGNITION OF SUBSTRATES AND ACTIVATORS BY THE OSR1 KINASE |
D |
A |
|
|
 |
2VNW |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (1-(9H-PURIN-6-YL)PIPERIDIN-4-YL)METHANAMINE |
I |
A |
|
|
 |
2VNY |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (1-(9H-PURIN-6-YL)PIPERIDIN-4-YL)AMINE |
I |
A |
|
|
 |
2VO0 |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH C-(4-(4-CHLOROPHENYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PIPERIDIN-4-YL)METHYLAMINE |
I |
A |
|
|
 |
2VO3 |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH C-(4-(4-CHLOROPHENYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PIPERIDIN-4-YL)METHYLAMINE |
I |
A |
|
|
 |
2VO6 |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 4-(4-CHLOROBENZYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PIPERIDIN-4-YLAMINE |
I |
A |
|
|
 |
2VO7 |
STRUCTURE OF PKA COMPLEXED WITH 4-(4-CHLOROBENZYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PIPERIDIN-4-YLAMINE |
I |
A |
Protein kinase-like (PK-like) |
|
 |
3BU3 |
Crystal structure of the insulin receptor kinase in complex with IRS2 KRLB peptide |
B |
A |
Protein kinase-like (PK-like) |
|
 |
3BU5 |
Crystal structure of the insulin receptor kinase in complex with IRS2 KRLB peptide and ATP |
B |
C |
|
|
 |
3C5I |
Crystal structure of Plasmodium knowlesi choline kinase, PKH_134520 |
E |
C |
|
|
 |
3CBL |
Crystal structure of human feline sarcoma viral oncogene homologue (v-FES) in complex with staurosporine and a consensus peptide |
B |
A |
|
|
 |
3CD3 |
Crystal structure of phosphorylated human feline sarcoma viral oncogene homologue (v-FES) in complex with staurosporine and a consensus peptide |
B |
A |
|
|
 |
3CQU |
Crystal Structure of Akt-1 complexed with substrate peptide and inhibitor |
C |
A |
|
|
 |
3CQW |
Crystal Structure of Akt-1 complexed with substrate peptide and inhibitor |
C |
A |
|
|
 |
3CXW |
Crystal structure of human proto-oncogene serine threonine kinase (PIM1) in complex with a consensus peptide and a beta carboline ligand I |
B |
A |
|
|